Skip to main content
. Author manuscript; available in PMC: 2017 Dec 14.
Published in final edited form as: Neurotoxicology. 2016 Aug 25;60:171–177. doi: 10.1016/j.neuro.2016.08.013

Table 1.

Effects of mutations within the two pyrethroid receptor sites on the action of DMT and PMT. Symbols ↓, ↑, and ≈indicate decrease, increase, or insignificant change of the ligand potency, respectively.

PyR1
PyR2
Mutant Ref.a DMT PMT DDT Mutant Ref.a DMT PMT DDT
L22k7F/I 1 ↓/↓ ≈/↑ I1k7A 3
M2k11T 1 V1k11A 3,6
S11o2A 5
L2o6I 1 L1o6I/A 3,5,6 ↑/≈ ≈/↑ ↑/
T22o10I 1 I1o10C 3,6
L22o13F 1 T1o13W/A 3,6 ≈/ ≈/ /≈
C22o14A 1
V2i18G 3 L1i18G 3
F2i22Sb 5,6 I11i22A 5,6
L22i25A 5,6 I11i25A 5,6
L22i26A 5
S1i29A 5
I3i12A 2,6 V22i12A/L 5,6 ≈/↑ ↑/↑ ≈/
F33i13C 3,6 I22i13M 3,6
S33i15A 2 N2i15S 5
F3i16A 2,6 L22i16F/S 3,6 ↓/↓ ↓/↓ ↓/
F33i17I 4
N3i20A 2 N2i20A 5
a

References: 1, (Usherwood et al., 2007); 2 (Du et al., 2009); 3 (Du et al., 2013) and references therein; 4 (Tan et al., 2005); 5, (Du et al., 2015); 6, (Du et al., 2016).

b

F2i22 contributes to both PyR1 and PyR2.